Skip to main content

Table 4 Baseline features of the studies which were included

From: Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis

Studies

Mean age

Males (%)

Ht (%)

Ds (%)

Cs (%)

DM (%)

 

E/F

E/F

E/F

E/F

E/F

E/F

FAST MI

67.0/66.5

71.0/72.0

58.0/66.0

45.5/52.5

27.0/32.0

23.0/25.0

OASIS 5

64.5/64.6

69.1/71.7

-

-

-

23.1/23.5

Schiele2010

-

71.0/66.0

52.0/57.0

49.0/55.0

32.0/31.0

21.0/20.0

Shah2014

-

77.8/74.4

55.6/55.6

-

58.9/55.6

41.1/38.9

Zhao2015

59.8/60.1

73.3/76.9

65.5/66.8

-

68.5/68.1

39.6/37.1

Zhao2016

58.2/57.3

78.2/76.3

59.5/57.2

-

53.0/52.1

20.3/22.8

Soeiro2016

61.8/61.0

62.6/65.7

73.6/67.8

51.2/48.9

30.5/24.2

46.9/55.8

  1. Abbreviations: E enoxaparin, F fondaparinux, Ht hypertension, Ds dyslipidemia, Cs current smoker, DM diabetes mellitus